Hjem › Steatotisk leversykdom › California › San Diego
Kliniske studier for Steatotisk leversykdom i San Diego, CA
14 studier for Steatotisk leversykdom søker deltakere på steder i og rundt San Diego (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekruttererFase 3
- 89bio Clinical Study Site, Coronado · 2 mi unna
- 89bio Clinical Study Site, La Jolla · 11 mi unna
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekruttererFase 3
- 89bio Clinical Study Site, Coronado · 2 mi unna
- 89bio Clinical Study Site, La Jolla · 11 mi unna
A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD
RekruttererFase 2
- Southern California Research Center, Coronado · 2 mi unna
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
RekruttererFase 2
- University of California San Diego NAFLD Research Center, La Jolla · 11 mi unna
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekruttererFase 2
- Southern California Research Center, Coronado · 2 mi unna
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekruttererFase 3
- Medical Associates Research Group, San Diego
- UCSD - Altman Clinical and Translational Research Institute (ACTRI), La Jolla · 11 mi unna
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekruttererFase 3
- Akero Clinical Study Site, Coronado · 2 mi unna
A Clinical Study to Investigate the Safety and Tolerability of Efimosfermin Alfa Injection in Participants With Known or Suspected F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, San Diego
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruttererFase 2
- UCSD Medical Center, La Jolla · 11 mi unna
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RekruttererFase 2
- GSK Investigational Site, Coronado · 2 mi unna
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekruttererFase 3
- GSK Investigational Site, San Diego
Accurate Point of Care Liver Disease Diagnostics (Phase 2)
RekruttererObservasjonsstudie
- University of California San Diego, La Jolla · 11 mi unna
Quantitative Ultrasound to Assess Steatotic Liver Disease in Children
RekruttererObservasjonsstudie
- University of California San Diego, La Jolla · 11 mi unna
Implementing Food Referrals for Equity and Sustained Health
RekruttererFase 2Frivillige helsepersonell ønskes velkommen
- Rady Children's Hospital San Diego, San Diego
Steatotisk leversykdom-studier i andre byer
- San Antonio, TX17 studier
- New York City, NY16 studier
- Miami, FL16 studier
- Austin, TX13 studier
- Houston, TX13 studier
- Richmond, VA12 studier
- Tucson, AZ10 studier
- Chandler, AZ10 studier
- Hialeah, FL9 studier
- Dallas, TX9 studier
- Orlando, FL9 studier
- St. Louis, MO9 studier
Andre studier i San Diego
- Ikke-småcellet lungekreft48 studier
- Brystkreft41 studier
- Kreft (alle typer)32 studier
- Prostatakreft31 studier
- Metastatisk kreft30 studier
- Kolorektal kreft25 studier
- Eggstokkreft24 studier
- Pankreaskreft24 studier
- Lungekreft23 studier
- Fedme23 studier
- Hjertesvikt23 studier
- Depresjon21 studier
Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.